Delivery Order SPE2DB20D3303-SPE2DB25FA2PN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Sulfamethoxazole-Trimethoprim DS tablets (500-count packages) with a ceiling value of $1,688.06. This firm fixed-price delivery order, which carries an ultimate completion date of August 28, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded a $1,174.63 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for sulfamethoxazole-trimethoprim DS tablets (500 count). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 22, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at the contractor's Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Sulfamethoxazole-Trimethoprim DS tablets in quantities of 100 units. The contract carries a ceiling value of $6,714.50 and employs a firm fixed price structure with an ultimate completion date of August 11, 2025. This is a non-set-aside delivery order, awarded competitively, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Sulfamethoxazole-Trimethoprim DS tablets (100-count) on July 28, 2025, with a ceiling value of $1,514.65. This competitive, non-set-aside delivery order is classified as firm fixed price and is scheduled for completion by July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,353.59 to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Sulfamethoxazole-Trimethoprim DS tablets in quantities of 100 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 3, 2025. The award represents a continuation of AmerisourceBergen's pharmaceutical supply services to the federal government, with performance occurring at the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Sulfamethoxazole-Trimethoprim DS tablets (100-count units) with a ceiling value of $5,185.10. This firm fixed-price delivery order, which is scheduled for completion by July 29, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work...
- The Defense Logistics Agency awarded a delivery order valued at $1,017.01 to AmerisourceBergen Drug Corp for the supply of Sulfamethoxazole-Trimethoprim DS tablets (500 count) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is structured as a child order...
- The Defense Logistics Agency awarded a delivery order valued at $3,132.64 to AmerisourceBergen Drug Corp for the supply of Sulfamethoxazole-Trimethoprim DS tablets (100-count packages) on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $1,628.73 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Sulfamethoxazole-Trimethoprim DS tablets (100 count). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 27, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for sulfamethoxazole-trimethoprim DS tablets (100-count bottles) valued at $4,627.09. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a non-set-aside competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is executed as a child order under AmerisourceBergen's larger...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2PNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Sulfamethoxazole-Trimethoprim DS tablets (500-count bottles) with a ceiling value of $1,297.28. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is a child contract issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across the Defense Health System. The Sulfamethoxazole-Trimethoprim DS tablets being supplied represent a widely-used antibiotic commonly prescribed for bacterial infections within military and veteran healthcare systems. Through its comprehensive IDC with DLA, AmerisourceBergen Drug Corp provides a broad spectrum of pharmaceutical products and medical supplies supporting military healthcare programs globally, including specialty medications, vaccines, generic and brand-name drugs, and various medical commodities. The August 15, 2025 ultimate completion date indicates this is a near-term delivery requirement under the broader pharmaceutical support arrangement with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/14/25 |